Found 7 matching trials
Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)
PHASE2This is a multicenter, phase 2b, open-label, non-randomized, clinical trial...
Status
Active Not Recruiting
Location
Soroka Medical Center
Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors
PHASE1Part 1: 16 to 32 patients with aggressive solid tumors from whom biopsies c...
Location
Clínica Universitaria Navarra
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
EARLY_PHASE1This early phase I trial evaluates the side effects of BO-112 and pembroliz...
Location
UCLA / Jonsson Comprehensive Cancer Center
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
PHASE1This phase I trial studies the side effects of BO-112 when given together w...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
PHASE2This is an open, single arm, multicenter phase 2 trial in which BO-112 will...
Location
Institut Jules Bordet
Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC
PHASE1This is a study of repeated IT administrations of BO-112 in combination wit...
Location
Clínica Universidad de Navarra
BO-112 With Pembrolizumab in Unresectable Malignant Melanoma
PHASE2This is a phase 2, single arm, open label, adaptive design study to determi...
Location
Centre Hospitalier Universitaire de Bordeaux